Back to Authors

Kesik, Esma

Mayo Clinic

Mayo Clinic in Arizona

Citations 1

Early Removal of Ureteral Stents When Attached to the Foley Catheter in Living Donor Kidney Transplant Recipients Reduces Urinary Tract Infections
Lam, Jenny , Mahgoub, Mohammed, Kesik, Esma, Smith, Byron H. , Ovdat, Esther , Rebolledo, Patricia , Bunn, Weslyn, Reddy, Kunam S. , Perry, Dana K. , Prieto, Mikel , Nyberg, Scott L. , Elali, Ibrahim, Kesik, Esma , Smith, Byron , Jadlowiec, Caroline , Mao, Shennen, Perry, Dana, Bentall, Andrew , Schinstock, Carrie , Nyberg, Scott, Stegall, Mark D , Elali, Ibrahim , Jadlowiec, Caroline C. , Mao, Shennen A. , Bentall, Andrew , Schinstock, Carrie A. , Stegall, Mark D.

Clinical Transplantation | September 24, 2025 | Volume: 39 | Issue: 10 | Pages: No page available

10.1111/ctr.70329 Get It

ABSTRACT Background Ureteral stents are commonly placed during kidney transplantation (KT) to mitigate urologic complications. The objective of this study was to compare clinical outcomes in KT recipients with either early stent removal when attached to the Foley catheter or late removal via cystoscopy when unattached. Methods We conducted a multi‐center retrospective analysis of consecutive living donor KT patients (8/18/21‐4/21/23) stratified into Foley‐attached and unattached stent groups. Outcomes assessed were ureteral stricture, urine leaks, UTIs at 90 days and allograft failure and BKV DNAemia (BK virus DNAemia) at 1 year. Data are reported as mean and standard deviation. Results Among 247 patients with attached and 260 with unattached stents, baseline demographics (age, sex, diabetes) were similar between groups. There was a difference in race (87.9% vs. 77.8% Caucasian; p = 0.004). Foley catheters remained longer in the attached group (3.7 ± 1.8 vs. 3.0 ± 2.0 days; p < 0.001), but stents were removed earlier (3.7 ± 1.8 vs. 21.9 ± 4.7 days; p < 0.001). Comparing attached versus unattached, there were no differences in ureteral stricture (0.4% vs. 1.5%; p = 0.197), urine leak (0.8% vs. 0.4%; p = 0.533), BKV DNAemia (17.7% vs. 16.9%; p = 0.616), or allograft failure (0% vs. 0.8%; p = 0.167). However, UTI incidence by 90 days was lower in the attached group (5.7% vs. 11.9% p = 0.013). Induction therapy differed significantly between groups, with Alemtuzumab more common in the unattached group (58.1% vs. 19.4%, p < 0.001), Basiliximab more common in the attached group (43.3% vs. 35.0%, p < 0.001), and Thymoglobulin more common in the attached group (36.0% vs. 6.9%, p < 0.001). Baseline steroid use was higher in the unattached group (81.9% vs. 57.9%, p < 0.001). Conclusion Early stent removal via connection to the Foley catheter had similarly low rates of ureteral complications while reducing urinary tract infections and avoiding cystoscopic removal.